TC
CBPO

TFS Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

TFS Capital’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,267
Closed -$889K – 985
2016
Q4 		$889K Sell
8,267
-1,227
-13% -$143K 0.24% 154
2016
Q3 		$1.18M Buy
+9,494
New +$1.12M 0.28% 128

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TFS Capital's CBPO Position: Q1 2017 in Review

TFS Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 8,267 shares — an estimated $889K sold.

TFS Capital first reported a position in CBPO in Q3 2016 and held it in 2 quarters. The position peaked at $1.18M in Q3 2016. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

  • TFS Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 8,267 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $889K.
  • TFS Capital first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 2 quarters.
  • TFS Capital's China Biologic Products Holdings, Inc. position peaked at $1.18M in Q3 2016.
  • 137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.